Neurofilaments, the biomarker that could mark the evolution of multiple sclerosis and other neurological diseases
In recent years, neurology is experiencing great advances, both in diagnosis and in the treatment of numerous diseases up to ...
In recent years, neurology is experiencing great advances, both in diagnosis and in the treatment of numerous diseases up to ...
Researchers at the Protein Diagnostic Center at the University of Ruhr de Bochum (Germany) and the Betanase Biotechnological Company have ...
An investigation carried out by a team from the Carlos III Health Institute (ISCIII) point to the activating receiver NKG2C ...
For years it is sought to identify Alzheimer's disease or dementias long before the first symptoms are presented. Now, according ...
An international study led by researchers from the Vall d'Hebron Institut d'Oncologia (Vhio) from Barcelona has highlighted the potential of ...
Researchers of the Mayo Clinic (USA) have identified a revolutionary biomarker, the interleukin-23 receptor (IL-23R), that could be key to ...
It will soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...